Belgie - angličtina - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sandoz sa-nv - rivaroxaban 2,5 mg - film-coated tablet - 2,5 mg - rivaroxaban 2.5 mg - rivaroxaban

Belgie - angličtina - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sandoz gmbh - rivaroxaban 2,5 mg - film-coated tablet - 2,5 mg - rivaroxaban 2.5 mg - rivaroxaban

Belgie - angličtina - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sandoz gmbh - rivaroxaban 10 mg - film-coated tablet - 10 mg - rivaroxaban 10 mg - rivaroxaban

Belgie - angličtina - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sandoz gmbh - rivaroxaban 15 mg - film-coated tablet - 15 mg - rivaroxaban 15 mg - rivaroxaban

Belgie - angličtina - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sandoz gmbh - rivaroxaban 20 mg - film-coated tablet - 20 mg - rivaroxaban 20 mg - rivaroxaban

Belgie - angličtina - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sandoz gmbh - rivaroxaban 15 mg (red tablet 15 mg); rivaroxaban 20 mg (brown-red tablet 20 mg) - film-coated tablet - 15 mg + 20 mg - rivaroxaban 15 mg; rivaroxaban 20 mg - rivaroxaban

Izrael - angličtina - Ministry of Health

k.s.kim international (sk- pharma) ltd., israel - rivaroxaban - film coated tablets - rivaroxaban 10 mg - rivaroxaban - prevention of venous thromboembolism (vte) in adult patients undergoing elective hip or knee replacement surgery. prevention of recurrent deep vein thrombosis (dvt) and pulmonary embolism (pe), in adults (following completion of at least 6 months therapy for dvt or pe).

Izrael - angličtina - Ministry of Health

k.s.kim international (sk- pharma) ltd., israel - rivaroxaban - film coated tablets - rivaroxaban 15 mg - rivaroxaban - prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation with one or more risk factors, such as congestive heart failure, hypertension, age≥75 years, diabetes mellitus, prior stroke or transient ischaemic attack. treatment of deep vein thrombosis (dvt),and pulmonary embolism (pe), and prevention of recurrent dvt and pe in adults

Izrael - angličtina - Ministry of Health

k.s.kim international (sk- pharma) ltd., israel - rivaroxaban - film coated tablets - rivaroxaban 20 mg - rivaroxaban - prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation with one or more risk factors, such as congestive heart failure, hypertension, age≥75 years, diabetes mellitus, prior stroke or transient ischaemic attack. treatment of deep vein thrombosis (dvt),and pulmonary embolism (pe), and prevention of recurrent dvt and pe in adults

Izrael - angličtina - Ministry of Health

dexcel ltd, israel - rivaroxaban - film coated tablets - rivaroxaban 2.5 mg - rivaroxaban - rivaroxaban dexcel 2.5 mg, co-administered with acetylsalicylic acid (asa) alone or with asa plus clopidogrel, is indicated for the prevention of atherothrombotic events in adult patients after an acute coronary syndrome (acs) with elevated cardiac biomarkers.rivaroxaban dexcel 2.5 mg, co-administered with acetylsalicylic acid (asa), is indicated for the prevention of atherothrombotic events in adult patients with coronary artery disease (cad) or symptomatic peripheral artery disease (pad) at high risk of ischaemic events.